Overall turnover has risen to $508m [€469m] during 2023 – up 42.87 per cent year-on-year Sirio Pharma (SIRIO) the global nutraceutical contract development and manufacturing organisation (CDMO) announces record revenues at Vitafoods Europe with international sales reaching near parity with domestic revenues for the first time. The CDMO, which is among the largest[Read More…]